Efficacy and Safety Study of Peginterferon Alfacon-2 to Treat Chronic Hepatitis B Virus Infection
Clinical trial NCT06544551 · COMPLETED
Trial details
- NCT number
- NCT06544551
- Sponsor
- Beijing Kawin Technology Share-Holding Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-28
- Primary completion
- 2023-11-30
- Enrollment
- 336
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.